Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
about
The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activitiesThe Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in RatsKininogen Cleavage Assay: Diagnostic Assistance for Kinin-Mediated Angioedema Conditions.Idiopathic Thrombocytopenic Purpura Misdiagnosed as Hereditary AngioedemaRole of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in miceDeficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection.A nationwide study of acquired C1-inhibitor deficiency in France: Characteristics and treatment responses in 92 patients.Factor XII: a novel target for safe prevention of thrombosis and inflammation.Optimizing hereditary angioedema management through tailored treatment approaches.The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.A flow cytometry-based assay for procoagulant platelet polyphosphate.How we manage persons with hereditary angioedema."Nuts and Bolts" of Laboratory Evaluation of Angioedema.HAE Pathophysiology and Underlying Mechanisms.The Story of Angioedema: from Quincke to Bradykinin.Factor XII: form determines function.Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy.Homozygosity for a factor XII mutation in one female and one male patient with hereditary angio-oedema.Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.The Search for Biomarkers in Hereditary Angioedema.Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1).F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema.Cell Receptor and Cofactor Interactions of the Contact Activation System and Factor XI.Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis.
P2860
Q26775616-5C753796-D12E-4B99-AAC3-6DC847747B42Q35905607-4B2DD952-ABC0-4974-AF7D-70AD06E8AB64Q36148583-5D3EAA23-1EF0-4123-A409-9F17A33F24C0Q36446974-1EA1C635-A370-4187-A13F-71CDD3F6D2F8Q36942043-259C5205-31D9-4A31-83C4-4844EC67268EQ37119024-B8BD90EC-88C4-4D5B-9246-A1B3A0F63117Q37261059-33DBBD96-82BF-4F7E-8E9C-3D9490E46409Q37726667-25A5CFF2-8C2F-40CC-9987-C4C04F3BE2F8Q38587540-639FDF17-EF3B-4F56-84CE-83225942C61EQ38615008-277A5261-FFFD-424B-9FAA-F0990CEEB586Q38632499-062E75EE-F303-4D23-8920-F88CF1637900Q38798595-E0D0045D-CBAF-4753-BDA1-36E6A51F4BC6Q38806437-1379E59E-8CF9-4441-AA40-C6E9005DF61DQ38824626-7F341F92-3744-495B-8E6B-87FA3F54358AQ38837708-5D66AAFA-0800-4D75-BF1C-55F28AC9DEB7Q38855032-15607086-B773-46F8-A9D4-5F519B485BC4Q38860396-A43F0CE8-AA9E-4BD0-A772-2EB7B085BB47Q39175404-C112C5BF-900D-42A1-B0E5-68D2B38BBCF1Q40988824-55A67C07-16B0-4576-9FDA-B83E0FEB3B79Q41665262-0EA0A6F9-34F4-495E-B25D-1CA8879EEE0DQ47139750-E3042976-1707-43CC-B74B-5368658ECAA0Q48113779-3ABB9E77-4044-4883-9864-A1468E41B57FQ50870747-AF7EFF33-757B-42D2-8450-A73B09D61DE2Q55052361-31E60338-5055-4A21-BF31-C6AE4176D188Q55416639-4E06E170-EEDB-4FE5-9F56-B6DB5C395012
P2860
Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Defective glycosylation of coa ...... hereditary angioedema type III
@ast
Defective glycosylation of coa ...... hereditary angioedema type III
@en
type
label
Defective glycosylation of coa ...... hereditary angioedema type III
@ast
Defective glycosylation of coa ...... hereditary angioedema type III
@en
prefLabel
Defective glycosylation of coa ...... hereditary angioedema type III
@ast
Defective glycosylation of coa ...... hereditary angioedema type III
@en
P2093
P2860
P50
P356
P1476
Defective glycosylation of coa ...... hereditary angioedema type III
@en
P2093
Antonio Di Gennaro
Chris Oschatz
Con Panousis
Hal Braley
Jenny Björkqvist
Kai Schönig
Marc W Nolte
Thomas Renné
Urs Lewandrowski
P2860
P304
P356
10.1172/JCI77139
P407
P577
2015-07-20T00:00:00Z